Blocking angiogenesis with peptides that inhibit the activity of procollagen C-endopeptidase

Pharmacological Reports

Volumn 61, Issue 3, 2009, Pages 468-475

  Lesiak, Marta ^a   Auguściak Duma, Aleksandra ^a   Szydło, Anna ^a   Sieroń, Aleksander L ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Angiogenesis; Anti angiogenic; Cell proliferation; Peptide inhibitors; Procollagen C endopeptidase BMP 1 mTLD; Tumorigenesis

Indexed keywords

PEPTIDE DERIVATIVE; PROCOLLAGEN C PROTEINASE;

AMINO ACID SEQUENCE; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ARTICLE; BLOOD VESSEL; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL TYPE; CHICK EMBRYO; CONTROLLED STUDY; EMBRYO; ENDOTHELIUM CELL; ENZYME INHIBITION; HUMAN; HUMAN CELL; NONHUMAN; PROTEIN FUNCTION; RAT; SKIN FIBROBLAST; UMBILICAL VEIN;

AMINO ACID SEQUENCE; ANGIOGENESIS INHIBITORS; ANIMALS; AORTA; BONE MORPHOGENETIC PROTEIN 1; CELL PROLIFERATION; CELLS, CULTURED; CHICK EMBRYO; GLYCOPROTEINS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MOLECULAR SEQUENCE DATA; NEOVASCULARIZATION, PHYSIOLOGIC; PEPTIDE FRAGMENTS; PEPTIDES; RATS;

EID: 67651151178     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/s1734-1140(09)70088-x     Document Type: Article

References (30)

1. Amano S, Scott IC, Takahara K, Koch M, Champliaud MF, Gerecke DR, Keene DR: Bone morphogenetic protein 1 is an extracellular processing enzyme of the laminin 5 γ 2 chain. J Biol Chem, 2000, 275, 22728-22735.
2. Auguściak-Duma A, Lesiak M, Pruszczyńska K, Kajor M, Piwowarczyk M, Sikora J, Sieroń AL. Quantitative changes of mRNAs encoding alternatively spliced variants of procollagen C-endopeptidase in leiomyomas uteri depending on phase of menstrual cycle and in menopause. Gin Pol, (submitted for publication after revision).
3. Byth HA, Mchunu BI, Dubery IA, Bornman L: Assessment of a simple, non-toxic Alamar blue cell survival assay to monitor tomato cell viability. Phytochem Anal, 2001, 12, 340-346.
4. Celik I, Surucu O, Dietz C, Heymach JV, Force J, Hoschele I, Becker CM: Therapeutic efficacy of endostatin exhibits a biphasic dose-response curve. Cancer Res, 2005, 65, 11044-11050.
5. Claesson-Welsh L, Welsh M, Ito N, Anand-Apte B, Soker S, Zetter B, O'Reilly M: Angiostatin induces endothelial cell apoptosis and activation of focal adhesion kinase independently of the integrin-binding motif RGD. Proc Natl Acad Sci USA, 1998, 95, 5579-5583.
6. Cronshaw AD, Fothergill-Gilmore LA, Hulmes DJS: The proteolytic processing site of the precursor of lysyl oxidase. Biochem J, 1995, 308, 279-284.
7. Dvorak HF, Brown LF, Detmar M, Dvorak AM: Vascular permeability factor/ vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol, 1995, 146, 1029-1039.
8. Folkman J: Antiangiogenic activity of a matrix protein. Cancer Biol Ther, 2003, 2, 53-54.
9. Folkman J, D'Amore PA: Blood vessel formation: what is its molecular basis? Cell, 1996, 87, 1153-1155.
10. Hojima Y, McKenzie JA, van der Rest M, Prockop DJ: Type I procollagen N-proteinase from chick embryo tendons. Purification of a new 500-kDa form of the enzyme and identification of the catalytically active polypeptides. J Biol Chem, 1989, 264, 11336-11345.
11. Hojima Y, van der Rest M, Prockop DJ: Type I procollagen carboxyl-terminal proteinase from chick embryo tendons. J Biol Chem, 1985, 260, 15996-16003.
12. Huh JI, Calvo A, Stafford J, Cheung M, Kumar R, Philp D, Kleinman HK: Inhibition of VEGF receptors significantly impairs mammary cancer growth in C3(1)/Tag transgenic mice through antiangiogenic and nonantiangiogenic mechanisms. Oncogene, 2005, 24, 790-800.
13. 2-terminal propeptide, and a furin-like proprotein convertase processes the COOH-terminal propeptide of pro-α1(V) collagen. J Biol Chem, 1998, 273, 27511-27517.
14. Jaffe EA, Nachman RL, Becker CG, Minick CR: Culture of human endothelial cells derived from umbilical veins. J Clin Invest, 1973, 11, 2745-2756.
15. Lesiak M, Auguściak-Duma A, Szydło A, Pruszczyńska K, Sieroń AL: Specific inhibition of procollagen C-endopeptidase activity by synthetic peptide with conservative sequence found in chordin. Acta Biochim Pol, 2008, 55, 297-305.
16. Li SW, Arita M, Fertala A, Bao Y, Kopen GC, Langsjo TK, Hyttinen MM: Transgenic mice with inactive alleles for procollagen N-proteinase (ADAMTS-2) develop fragile skin and male sterility. Biochem J, 2001, 355, 271-278.
17. Li SW, Sieron AL, Fertala A, Hojima Y, Arnold WV, Prockop DJ: The C-proteinase that processes procollagens to fibrillar collagens is identical to the protein previously identified as bone morphogenic protein-1. Proc Natl Acad Sci USA, 1996, 93, 5127-5130.
18. Li W, Nellaiappan K, Strassmaier T, Graham L, Thomas KM, Kagan HM: Localization and activity of lysyl oxidase within nuclei of fibrogenic cells. Proc Natl Acad Sci USA, 1997, 94, 12817-12822.
19. Aird WC: Endothelium in health and disease. Pharmacol Rep, 2008, 60, 139-143.
20. Schmidt VJ, Wölfle SE, Boettcher M, de Wit C: Gap junctions synchronize vascular tone within the microcirculation. Pharmacol Rep. 2008, 60, 68-74.
21. Nicosia RF, Ottinetti A: Growth of microvessels in serum-free matrix culture of rat aorta. A quantitative assay of angiogenesis in vitro. Lab Invest, 1990, 63, 115-122.
22. Panchenko MV, Stelter-Stevenson WG, Trupetskoy OV, Gacheru SN, Kagan HM: Metalloproteinase activity secreted by fibrogenic cells in the processing of prolysyl oxidase. Potential role of procollagen C-proteinase. J Biol Chem, 1996, 271, 7113-7119.
23. Prockop DJ, Kivirikko KI, Tuderman L, Guzman NA: Biosynthesis of collagen. N Engl J Med, 1979, 301, 12-23.
24. Prockop DJ, Kivirikko KI: Heritable diseases of collagen. N Engl J Med, 1984, 311, 376-386.
25. Qian X, Wang TN, Rothman VL, Nicosia RF, Tuszynski GP: Thrombospondin-1 modulates angiogenesis in vitro by up-regulation of matrix metalloproteinase-9 in endothelial cells. Exp Cell Res, 1997, 235, 403-412.
26. Risau W: Mechanisms of angiogenesis. Nature, 1997, 386, 671-674.
27. Senger DR: Molecular framework for angiogenesis: a complex web of interactions between extravasated plasma proteins and endothelial cell proteins induced by angiogenic cytokines. Am J Pathol, 1996, 149, 1-7.
28. Sun J, Wang DA, Jain RK, Carie A, Paquette S, Ennis E, Blaskovich MA: Inhibiting angiogenesis and tumorigenesis by a synthetic molecule that blocks binding of both VEGF and PDGF to their receptors. Oncogene, 2005, 24, 4701-4709.
29. Suzuki N, Labosky PA, Furuta Y, Hargett L, Dunn R, Fogo AB, Takahara K: Failure of ventral body wall closure in mouse embryos lacking a procollagen C-proteinase encoded by BMP-1, a mammalian gene related to Drosophila tolloid. Development, 1996, 122, 3587-3595.
30. Tuszynski GP, Nicosia RF: The role of thrombospondin-1 in tumor progression and angiogenesis. Bioessays, 1996, 18, 71-76.